Biotoxtech Balance Sheet Health
Financial Health criteria checks 1/6
Biotoxtech has a total shareholder equity of ₩42.4B and total debt of ₩57.7B, which brings its debt-to-equity ratio to 136.2%. Its total assets and total liabilities are ₩136.7B and ₩94.3B respectively.
Key information
136.2%
Debt to equity ratio
₩57.75b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩31.42b |
| Equity | ₩42.41b |
| Total liabilities | ₩94.28b |
| Total assets | ₩136.69b |
Recent financial health updates
Is Biotoxtech (KOSDAQ:086040) A Risky Investment?
May 06
Is Biotoxtech (KOSDAQ:086040) Using Too Much Debt?
Nov 30
Recent updates
Improved Revenues Required Before Biotoxtech Co., Ltd. (KOSDAQ:086040) Shares Find Their Feet
Oct 21Is Biotoxtech (KOSDAQ:086040) A Risky Investment?
May 06Estimating The Fair Value Of Biotoxtech Co., Ltd. (KOSDAQ:086040)
Mar 28Did Biotoxtech's (KOSDAQ:086040) Share Price Deserve to Gain 91%?
Feb 20Are Robust Financials Driving The Recent Rally In Biotoxtech Co., Ltd.'s (KOSDAQ:086040) Stock?
Jan 24We're Not So Sure You Should Rely on Biotoxtech's (KOSDAQ:086040) Statutory Earnings
Dec 27Is Biotoxtech (KOSDAQ:086040) Using Too Much Debt?
Nov 30Financial Position Analysis
Short Term Liabilities: A086040's short term assets (₩53.9B) do not cover its short term liabilities (₩72.1B).
Long Term Liabilities: A086040's short term assets (₩53.9B) exceed its long term liabilities (₩22.2B).
Debt to Equity History and Analysis
Debt Level: A086040's net debt to equity ratio (62.1%) is considered high.
Reducing Debt: A086040's debt to equity ratio has increased from 57% to 136.2% over the past 5 years.
Debt Coverage: A086040's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if A086040's interest payments on its debt are well covered by EBIT.